Detalhe da pesquisa
1.
A real-world analysis of PD1 blockade from the Rete Ematologica Pugliese (REP) in patients with relapse/refractory Hodgkin's lymphoma.
Ann Hematol;
102(2): 385-392, 2023 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36645458
2.
Evaluating the Use of a Robot in a Hematological Intensive Care Unit: A Pilot Study.
Sensors (Basel);
23(20)2023 Oct 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37896459
3.
Impact of total body irradiation- vs chemotherapy-based myeloablative conditioning on outcomes of haploidentical hematopoietic cell transplantation for acute myelogenous leukemia.
Am J Hematol;
95(10): 1200-1208, 2020 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32656791
4.
Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO Group.
Biol Blood Marrow Transplant;
25(5): 932-940, 2019 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30579966
5.
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO).
Biol Blood Marrow Transplant;
25(12): 2388-2397, 2019 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31400502
6.
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.
N Engl J Med;
374(1): 43-53, 2016 Jan 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26735993
7.
Brentuximab vedotin prior to allogeneic stem cell transplantation increases survival in chemorefractory Hodgkin's lymphoma patients.
Ann Hematol;
98(6): 1449-1455, 2019 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30868307
8.
Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM.
Blood;
127(23): 2833-40, 2016 06 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27091875
9.
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial.
Haematologica;
103(5): 849-856, 2018 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29472356
10.
Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
Lancet Oncol;
18(8): 1076-1088, 2017 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28668386
11.
Autologous transplantation and maintenance therapy in multiple myeloma.
N Engl J Med;
371(10): 895-905, 2014 Sep 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25184862
12.
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma.
Haematologica;
102(11): 1931-1935, 2017 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28775121
13.
A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up.
Acta Haematol;
137(1): 7-14, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27820922
14.
Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients.
Haematologica;
101(10): 1200-1207, 2016 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27470600
15.
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial.
Lancet Oncol;
16(15): 1525-1536, 2015 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26429297
16.
Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study.
Lancet Oncol;
16(9): 1025-1036, 2015 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26234174
17.
Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study.
Blood;
121(25): 5055-63, 2013 Jun 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23482933
18.
Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study.
Blood;
122(16): 2799-806, 2013 Oct 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23954889
19.
Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial.
Lancet Oncol;
15(7): 730-7, 2014 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24831981
20.
Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.
Biol Blood Marrow Transplant;
20(10): 1573-9, 2014 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24910379